CRIPTO and non-small cell lung carcinoma: Definitive implication of CRIPTO in NSCLC relapse and progression may lead to targeted therapeutic approaches aimed at interfering with post-chemotherapy CSCs expansion and to the use of CRIPTO as a marker/readout of chemotherapy-induced CSC expansion.